If You Blow the Whistle, Are You Protected?

The Sarbanes-Oxley Act has added a wrinkle to whistleblower protections first outlined in 1989. This exhaustive research by Harvard third-year law student John Rouse outlines protections for FDA and private-sector pharmaceutical employees, with a special look at the implications of Dr. David Graham’s criticism of FDA’s oversight of Vioxx.

By John Rouse

If you are not automatically redirected, follow this link:
http://leda.law.harvard.edu/leda/data/712/Rouse05.html

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments